VMD — Viemed Healthcare Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual income statement for Viemed Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	131	117	139	183	224
Cost of Revenue
Gross Profit	80.1	73.4	84.7	113	133
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	105	105	131	169	206
Operating Profit	26.8	11.6	8.25	14.3	17.9
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	26.4	12.5	8.99	14.4	16.2
Provision for Income Taxes
Net Income After Taxes	31.5	9.13	6.22	10.2	11.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	31.5	9.13	6.22	10.2	11.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	31.5	9.13	6.22	10.2	11.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.741	0.232	0.162	0.265	0.243